Obesity was associated with worse disease activity and disease management in both PsA and RA [12,15,16,17,18,19,20,21] and a detrimental response to anti-tumor necrosis factor alpha (anti-TNF) treatments [15,17,18]. The gene discussed is TNF; the disease is obesity due to melanocortin 4 receptor deficiency.